Phase 2 Committee
Membership 2008
Membership is for a period of two years. The Presiding Member of the committee will be invited to become a member of the CDC.
| Presiding Member - (to be elected by the Committee) | Associate Professor Andrew Cole |
| Presiding Member of the Faculty (ex officio) | Professor Minoti Apte |
| Associate Dean, Education (ex officio) | Associate Professor Phil Jones |
| Primary course convenors for each Phase 2 course (4) |  |
Society & Health
| Professor Mark Harris
Dr Suzanne McKenzie
Dr Catherine Berglund (School Rep.)
Dr Alix Magney (School Rep.)
Ms Leah Bloomfield (co convenor) |
| Beginnings, Growth & Development | Dr Andrew Day
Dr Terri Foran |
| Health Maintenance | Dr Tony Grabs |
| Ageing & Endings | Associate Professor Andrew Cole |
| A representative from the Clinical Learning and Assessment Committee | Associate Professor Eva Segelov |
| A convenor of the Medical Ethics program element | Dr Adrienne Torda |
| A representative of the Independent Learning Project Committee | Dr John Hunt |
| At least one representative from the School of Medical Sciences | Dr Gary Velan |
| Additional members as suggested by the CDC to ensure broad representation on the committee from clinical teaching sites and the social and biomedical sciences | |
| - Prince of Wales Clincial School | Dr Silas Taylor |
| - School of Psychiatry/QMP | Dr Rachel Thompson |
| - St George Clinical School | Associate Professor Michael Grimm |
| - St Vincent's Clinical School | Dr Tony Grabs |
| - South Western Sydney Clinical School | Dr Jude Ng |
| - Sutherland Hospital | Dr Peter Gonski |
| - Rural Clinical School | Dr Lesley Forster |
| Office of Medical Education | Dr Chris Hughes |
| Undergraduate Student Representative | Ms Yumiko Kadota |
| In Attendance | |
| Representative of the Office of the Dean | Mr Gordon Rees |
| Representative of the Office of Medical Education | Ms Elena Mankovskaia |
| Secretarial Support | |
| Office of Medical Education | Ms Elena Mankovskaia |
Formation
The Curriculum Development Committee (CDC) resolved at its meeting on April 2, 2003 to:
– form Phase Committees for Phases 1, 2 and 3 of the new Medicine program 3802, and
– that membership and roles of these committees will evolve over time,
– that members will be appointed by CDC, and
– that CDC will have an oversight role of the Phase Committees.
Functions
- To continuously develop a framework or blueprint for the phase, which effectively integrates its component courses.
- To review teaching, learning and assessment activities submitted by course convenors, to ensure that assessments are integrated and aligned with graduate capabilities and teaching activities; the phase committee will have the authority to accept or reject such activities for a course.
- To convene groups to set assessments according to the requirements of the blueprint.
- To develop standard-setting procedures and examiner training for portfolio marking.
- To oversee the conduct and marking of assessments (assignments and projects), portfolio reviews and the training of examiners/markers.
- To review evaluation and assessment data for the phase, and suggest modifications to content and design of teaching activities and assessment as appropriate.